Cardiovascular disease and the kidney: Tracking a killer in chronic kidney disease

Postgraduate Medicine

Volumn 111, Issue 4, 2002, Pages 53-60

  Levin, Adeera ^a,b   Stevens, Lesley ^a   McCullough, Peter A ^c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d TRUMAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREDNISONE;

ANEMIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DIABETES CONTROL; DRUG EFFECT; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PROTEINURIA; REVIEW; RISK FACTOR;

EID: 0036117993     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2002.04.1168     Document Type: Review

References (31)

1. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey
2. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
3. Incidence of atherosclerotic arterial occlusive accidents in predialysis and dialysis patients: A multicentric study in the Ile de France district
4. Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project
5. Patient mortality and survival
6. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
7. Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
8. Cardiovascular disease after renal transplantation
9. Long-term changes in left ventricular hypertrophy after renal transplantation
10. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction
11. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
12. Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study
13. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States
14. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
15. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
16. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
17. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
18. Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter
19. Risks associated with renal dysfunction in the coronary care unit
20. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
21. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men
22. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
23. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus
24. Preserving renal function in adults with hypertension and diabetes: A consensus approach
25. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A metaanalysis of randomized trials
26. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?
27. Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy
28. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
30. Plasma lipids and risk of developing renal dysfunction: The atherosclerosis risk in communities study
31. A randomized placebo-controlled double-blind trial of lipid-lowering strategies in patients with renal insufficiency: Diet modification with or without fenofibrate